Understanding the Multiple Dimensions of Ageing: 5Ms for the Rheumatologist

Overview

Journal Lancet Rheumatol

Specialty Rheumatology

Date 2024 Nov 14

PMID 39542005

Authors

Bjoern Buehring

Marloes van Onna

Elena Myasoedova

Jiha Lee

Una E Makris

Affiliations

Soon will be listed here.

Abstract

The global population is ageing and the rheumatology workforce should be prepared to take care of the inevitable complexities of ageing patients. We can learn from our colleagues and experts in geriatrics about how best to manage multimorbidity, polypharmacy, geriatric syndromes, and shifting priorities of older patients in the context of delivering care for rheumatic diseases. One approach to learning and adopting key ageing constructs within rheumatology practice is to incorporate the established Geriatric 5Ms-principles fundamental to caring for older adults. In this Series paper we discuss the 5Ms in the context of rheumatology practice (1) multicomplexity: assessing and managing multimorbidity and challenging biopsychosocial situations, (2) medications: ensuring that medications do not interfere with the other Ms, (3) mind: managing neurocognitive disorders and comorbid mental health conditions, (4) mobility: ensuring older adults can move independently and safely, and (5) what matters most: aligning care with an older adult's specific goals.

References

Conradi H, Ormel J, de Jonge P . Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2010; 41(6):1165-74. DOI: 10.1017/S0033291710001911. View

Kahler J, Mastarone G, Matsumoto R, ZuZero D, Dougherty J, Barton J . "It may help you to know…": The Early-phase Qualitative Development of a Rheumatoid Arthritis Goal Elicitation Tool. J Rheumatol. 2021; 49(2):142-149. PMC: 8720108. DOI: 10.3899/jrheum.201615. View

Schett G, Emery P, Tanaka Y, Burmester G, Pisetsky D, Naredo E . Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Ann Rheum Dis. 2016; 75(8):1428-37. DOI: 10.1136/annrheumdis-2016-209201. View

Carroll M, Parmar P, Dalbeth N, Boocock M, Rome K . Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2015; 16:134. PMC: 4455329. DOI: 10.1186/s12891-015-0596-0. View

George J, Phun Y, Bailey M, Kong D, Stewart K . Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004; 38(9):1369-76. DOI: 10.1345/aph.1D479. View

Dent E, Morley J, Cruz-Jentoft A, Arai H, Kritchevsky S, Guralnik J . International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018; 22(10):1148-1161. DOI: 10.1007/s12603-018-1139-9. View

Rayes H, Tani C, Kwan A, Marzouk S, Colosimo K, Medina-Rosas J . What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum. 2018; 48(2):240-255. DOI: 10.1016/j.semarthrit.2018.02.007. View

Yuen K, Bingham K, Tayer-Shifman O, Touma Z . Measures of Cognition in Rheumatic Diseases. Arthritis Care Res (Hoboken). 2020; 72 Suppl 10:660-675. DOI: 10.1002/acr.24364. View

Petersen R, Lopez O, Armstrong M, Getchius T, Ganguli M, Gloss D . Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017; 90(3):126-135. PMC: 5772157. DOI: 10.1212/WNL.0000000000004826. View

10.

Stewart C, Stewart J, Stubbs S, Epling J . Mini-Cog, IQCODE, MoCA, and MMSE for the Prediction of Dementia in Primary Care. Am Fam Physician. 2022; 105(6):590-591. View

11.

OMahony D, Cherubini A, Renom Guiteras A, Denkinger M, Beuscart J, Onder G . STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023; 14(4):625-632. PMC: 10447584. DOI: 10.1007/s41999-023-00777-y. View

12.

Hossain M, Kopec J, Atiquzzaman M, Karim M . The association between rheumatoid arthritis and cardiovascular disease among adults in the United States during 1999-2018, and age-related effect modification in relative and absolute scales. Ann Epidemiol. 2022; 71:23-30. DOI: 10.1016/j.annepidem.2022.03.005. View

13.

Myasoedova E, Sattui S, Lee J, OBrien J, Makris U . Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities. Lancet Rheumatol. 2024; 6(12):e871-e880. PMC: 11827066. DOI: 10.1016/S2665-9913(24)00190-5. View

14.

Bay L, Ellingsen T, Giraldi A, Graugaard C, Nielsen D . "To be lonely in your own loneliness": The interplay between self-perceived loneliness and rheumatoid arthritis in everyday life: A qualitative study. Musculoskeletal Care. 2020; 18(4):450-458. DOI: 10.1002/msc.1480. View

15.

van Leeuwen K, van Loon M, van Nes F, Bosmans J, de Vet H, Ket J . What does quality of life mean to older adults? A thematic synthesis. PLoS One. 2019; 14(3):e0213263. PMC: 6407786. DOI: 10.1371/journal.pone.0213263. View

16.

Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A . The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates. Front Med (Lausanne). 2018; 5:61. PMC: 5890129. DOI: 10.3389/fmed.2018.00061. View

17.

Tinetti M, Fried T, Boyd C . Designing health care for the most common chronic condition--multimorbidity. JAMA. 2012; 307(23):2493-4. PMC: 4083627. DOI: 10.1001/jama.2012.5265. View

18.

Seguin D, Peschken C, Dolovich C, Grymonpre R, St John P, Tisseverasinghe A . Polypharmacy and Potentially Inappropriate Medication Use in Older Adults With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2021; 75(2):356-364. DOI: 10.1002/acr.24766. View

19.

Hiligsmann M, Beaudart C, Bruyere O, Biver E, Bauer J, Cruz-Jentoft A . Outcome Priorities for Older Persons With Sarcopenia. J Am Med Dir Assoc. 2019; 21(2):267-271.e2. PMC: 7021510. DOI: 10.1016/j.jamda.2019.08.026. View

20.

Lee J, Singh N, Gray S, Makris U . Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More. ACR Open Rheumatol. 2022; 4(12):1031-1041. PMC: 9746667. DOI: 10.1002/acr2.11503. View